Sign up to save your podcasts
Or
Share The Lollipop War Has Begun
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lollipop War Has Begun
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.
Get $50 off your first job post at www.LinkedIn.com/Fool.
View all episodes
By The Motley Fool
4.7
16081,608 ratings
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.
Get $50 off your first job post at www.LinkedIn.com/Fool.
More shows like MarketFoolery
View all
Mad Money w/ Jim Cramer
4,096 Listeners
Investing Insights
483 Listeners
Motley Fool Money
3,179 Listeners
Industry Focus
828 Listeners
Masters in Business
2,181 Listeners
Money For the Rest of Us
1,375 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,367 Listeners
Motley Fool Answers
806 Listeners
InvestED: The Rule #1 Investing Podcast
1,493 Listeners
Rule Breaker Investing
931 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,290 Listeners
Bogleheads On Investing Podcast
582 Listeners
Investing With IBD
380 Listeners
The Long View
864 Listeners
Barron's Streetwise
1,529 Listeners
The Memo by Howard Marks
400 Listeners
The Investopedia Express with Caleb Silver
232 Listeners